A pneumonia outbreak associated with a new coronavirus of probable bat origin.

PubWeight™: 9.42‹?› | Rank: Top 0.1%

🔗 View Article (PMID 32015507)

Published in Nature on February 03, 2020

Authors

Peng Zhou1, Xing-Lou Yang1, Xian-Guang Wang2, Ben Hu1, Lei Zhang1, Wei Zhang1, Hao-Rui Si1,3, Yan Zhu1, Bei Li1, Chao-Lin Huang2, Hui-Dong Chen2, Jing Chen1,3, Yun Luo1,3, Hua Guo1,3, Ren-Di Jiang1,3, Mei-Qin Liu1,3, Ying Chen1,3, Xu-Rui Shen1,3, Xi Wang1,3, Xiao-Shuang Zheng1,3, Kai Zhao1,3, Quan-Jiao Chen1, Fei Deng1, Lin-Lin Liu4, Bing Yan1, Fa-Xian Zhan4, Yan-Yi Wang1, Geng-Fu Xiao1, Zheng-Li Shi5

Author Affiliations

1: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
2: Wuhan Jin Yin-Tan Hospital, Wuhan, China.
3: University of Chinese Academy of Sciences, Beijing, China.
4: Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
5: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China. zlshi@wh.iov.cn.

Associated clinical trials:

A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 | NCT04324996

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection (GARM-COVID19) | NCT04326036

Hemodynamic Characteristics of Patients With SARS-CoV-2 (PiCCOVID) | NCT04337983

Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives | NCT04357535

COVID-19 Patient Positioning Pragmatic Trial | NCT04359797

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 (TREATNOW) | NCT04372628

Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS | NCT04374149

Effect of COVID-19 Pandemic on Pediatric Cancer Care | NCT04374838

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 | NCT04380870

Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260

Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients | NCT04465552

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | NCT04516746

Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial | NCT04548557

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. (PROVENT) | NCT04625725

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults (STORM CHASER) | NCT04625972

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults (TACKLE) | NCT04723394

Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death | NCT04914832

COVID Vaccine Response in MS | NCT05060354